Ihuman Historical Financial Ratios
| IH Stock | USD 1.52 0.03 1.94% |
Ihuman is lately reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.34 will help investors to properly organize and evaluate Ihuman Inc financial condition quickly.
Ihuman |
About Ihuman Financial Ratios Analysis
Ihuman IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Ihuman investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Ihuman financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Ihuman history.
Ihuman Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Ihuman Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Ihuman sales, a figure that is much harder to manipulate than other Ihuman Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Ihuman Inc dividend as a percentage of Ihuman stock price. Ihuman Inc dividend yield is a measure of Ihuman stock productivity, which can be interpreted as interest rate earned on an Ihuman investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Operating Cash Flow Per Share
A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Most ratios from Ihuman's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Ihuman Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, Ihuman's Book Value Per Share is increasing as compared to previous years. The Ihuman's current Free Cash Flow Yield is estimated to increase to 0.14, while Price To Sales Ratio is projected to decrease to 1.14.
| 2023 | 2024 (projected) | Dividend Yield | 0.0111 | 0.0117 | Price To Sales Ratio | 1.2 | 1.14 |
Ihuman fundamentals Correlations
Click cells to compare fundamentals
Ihuman Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ihuman fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 23.06 | 10.06 | 1.0 | 0.97 | 1.2 | 1.14 | |
| Ptb Ratio | (349.02) | 8.33 | 1.55 | 1.24 | 1.27 | 1.34 | |
| Days Sales Outstanding | 35.03 | 53.72 | 22.79 | 30.33 | 22.46 | 37.04 | |
| Book Value Per Share | (0.32) | 14.2 | 11.49 | 14.43 | 17.47 | 18.35 | |
| Operating Cash Flow Per Share | 0.94 | 4.93 | 0.72 | 3.54 | 3.14 | 1.75 | |
| Capex To Depreciation | 4.01 | 5.65 | 5.03 | 0.61 | 0.56 | 0.53 | |
| Pb Ratio | (349.02) | 8.33 | 1.55 | 1.24 | 1.27 | 1.34 | |
| Ev To Sales | 22.58 | 8.45 | 0.13 | (0.0863) | 0.007761 | 0.007373 | |
| Free Cash Flow Per Share | 0.89 | 4.57 | 0.11 | 3.41 | 3.02 | 1.58 | |
| Roic | 19.39 | (0.07) | (0.0888) | 0.12 | 0.15 | 0.14 | |
| Inventory Turnover | 4.07 | 9.87 | 10.13 | 15.39 | 17.97 | 18.87 | |
| Net Income Per Share | (6.09) | (0.83) | (0.7) | 2.06 | 3.3 | 3.47 | |
| Days Of Inventory On Hand | 89.62 | 37.0 | 36.04 | 23.72 | 20.31 | 19.29 | |
| Payables Turnover | 8.17 | 7.72 | 9.3 | 12.16 | 13.41 | 7.44 | |
| Research And Ddevelopement To Revenue | 0.78 | 0.38 | 0.44 | 0.32 | 0.25 | 0.47 | |
| Capex To Revenue | 0.0109 | 0.0299 | 0.0342 | 0.006685 | 0.006393 | 0.0122 | |
| Cash Per Share | 2.32 | 19.04 | 16.16 | 19.7 | 22.14 | 23.25 | |
| Pocfratio | 118.31 | 24.0 | 24.64 | 5.07 | 7.08 | 7.43 | |
| Capex To Operating Cash Flow | 0.0561 | 0.0713 | 0.84 | 0.035 | 0.0378 | 0.0359 | |
| Pfcf Ratio | 125.34 | 25.85 | 158.73 | 5.26 | 7.35 | 7.72 | |
| Days Payables Outstanding | 44.68 | 47.25 | 39.23 | 30.02 | 27.22 | 47.88 | |
| Income Quality | (0.15) | (5.95) | (1.03) | 1.72 | 0.95 | 1.0 | |
| Roe | 19.07 | (0.0583) | (0.0609) | 0.14 | 0.19 | 0.18 | |
| Ev To Operating Cash Flow | 115.84 | 20.17 | 3.15 | (0.45) | 0.0459 | 0.0482 | |
| Pe Ratio | (18.3) | (142.82) | (25.41) | 8.7 | 6.73 | 7.07 | |
| Ev To Free Cash Flow | 122.73 | 21.72 | 20.28 | (0.47) | 0.0477 | 0.0501 | |
| Earnings Yield | (0.0546) | (0.007002) | (0.0394) | 0.11 | 0.15 | 0.16 | |
| Intangibles To Total Assets | 6.12E-4 | 0.0113 | 0.0248 | 0.0187 | 0.016 | 0.00984 | |
| Net Debt To E B I T D A | 0.38 | 20.54 | 17.17 | (8.5) | (7.05) | (6.7) | |
| Current Ratio | 0.89 | 2.56 | 2.1 | 2.23 | 2.82 | 1.48 | |
| Tangible Book Value Per Share | (0.32) | 13.94 | 10.98 | 13.97 | 17.05 | 17.9 | |
| Receivables Turnover | 10.42 | 6.79 | 16.02 | 12.03 | 16.25 | 9.5 | |
| Graham Number | 6.61 | 16.26 | 13.45 | 25.87 | 36.02 | 37.82 | |
| Shareholders Equity Per Share | (0.32) | 14.2 | 11.49 | 14.43 | 17.47 | 18.35 |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Earnings Share (0.16) | Revenue Per Share 18.263 | Quarterly Revenue Growth (0.11) | Return On Assets 0.0456 |
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.